RE: Life Science Leader - Podcast - Just out10 May 2022 11:59
Sileng... there is funding, to my knowledge for another 5 months, during which period we are expecting an update from Oxford Finance, vaccine payment and any other revenue source (we might not even be aware of currently)
SP is in decline- but so is the entire biotech market. Look at XBI. Most of Nasdaq bitech in high single/low double digits red territory. Bloodbath. So, not specific only to 4D I think.
And is there something brewing? Well, in my opinion, I think there is. I have absolutely no proof but do belive that 4D management are not sitting idle. Again, no proof but simply a gut feel based on management statements and the strength of 4D's pipeline.
So yes, I don't think k wild ramping is helpful here but perhaps the situation is not as catastrophic as it seems (it is bad , I agree, and XBI dropping like we are under alien attack is not for everyone).
Jus my opinion, not an expert. Or an advisor. Just a worried but cautiously optimistic 4D investor.